Hathaway, L., Sen, J. M., & Keng, M. (2018). Impact of blinatumomab on patient outcomes in relapsed/refractory acute lymphoblastic leukemia: Evidence to date. Patient Relat Outcome Meas.
Chicago Stili AlıntıHathaway, Lindsey, Jeremy Michael Sen, ve Michael Keng. "Impact of Blinatumomab On Patient Outcomes in Relapsed/refractory Acute Lymphoblastic Leukemia: Evidence to Date." Patient Relat Outcome Meas 2018.
MLA AlıntıHathaway, Lindsey, Jeremy Michael Sen, ve Michael Keng. "Impact of Blinatumomab On Patient Outcomes in Relapsed/refractory Acute Lymphoblastic Leukemia: Evidence to Date." Patient Relat Outcome Meas 2018.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..